미국과 한국에서 NeuroMatch가 출시되었습니다. 더 알아보기:

LVIS at KIMES 2025: Pioneering the Future of Brain Health with NeuroMatch and AI Innovation

The 40th Korea International Medical & Hospital Equipment Show (KIMES 2025), held from March 20th to 23rd at the COEX Exhibition Center in Seoul, was a monumental event in the medical industry. 

With over 1,450 companies showcasing approximately 37,000 state-of-the-art medical devices and hospital equipment, KIMES 2025 celebrated its 40th anniversary. The event also highlighted the latest advancements and trends across multiple sectors of healthcare.

Covering an impressive 45,000㎡, KIMES 2025 brought together innovations spanning diagnostic devices, surgical instruments, rehabilitation equipment, and much more. The exhibition was a platform for exploring breakthroughs in medical technology, including artificial intelligence (AI), big data, and the convergence of these technologies within healthcare.

As the industry embraces these advancements, LVIS Corporation proudly took center stage, introducing our revolutionary NeuroMatch platform to the world.

The Role of LVIS in Brain Health Innovation

In March, we had the privilege of standing at the forefront of technological innovation at KIMES 2025, where the LVIS Corporation team proudly showcased our groundbreaking NeuroMatch platform.

NeuroMatch, an advanced digital medical device created to manage and treat brain diseases, captivated healthcare professionals and institutions alike.

Our participation wasn’t just about showcasing a product; it was about demonstrating our long-standing commitment to advancing brain health. This was a chance to share our expertise in harnessing AI to transform how brain-related conditions are treated and managed.

Professor Jin Hyung Lee & Her Vision for the Future of AI and Brain Health

Professor Jin Hyung Lee, founder of LVIS Corporation, was a major highlight at KIMES 2025. 

As a prominent speaker at the “AI Era Brain Health Innovation Forum,” Professor Lee shared invaluable insights into the future of artificial intelligence in brain health. Her presentation, titled “The Future of Artificial Intelligence and Brain Health,” captivated the audience, sparking discussions on the potential of AI in diagnosing, treating, and understanding neurological conditions.

The forum, hosted by the Korea Health Industry Association, served as a powerful moment for the exchange of ideas between industry leaders, researchers, and medical professionals. Together, we further positioned AI as a critical force in healthcare innovation.

KIMES 2025: A Landmark Event for Healthcare Innovation

KIMES 2025 served as a significant milestone for the global medical device industry. With the emphasis on AI and big data, the event provided a broad look at the future of healthcare technologies. 

As Korea’s medical sector continues to grow in global prominence, KIMES 2025 underscored the nation’s commitment to driving innovation and increasing its competitiveness on the world stage.

At LVIS Corporation, we are proud to have been part of such an impactful event and are excited to continue our work in advancing the field of brain health. 

The success of KIMES 2025 marks a pivotal moment for our company as we continue to bring AI-powered solutions to the medical community, helping to shape the future of brain research and wellness.

Stay tuned for more updates from LVIS as we work to transform the landscape of healthcare with our innovative technologies.

Leave a Comment